Sertraline-Induced Lipase-Sparing Acute Interstitial Edematous Pancreatitis: A Case Report
Abstract Sertraline, a selective serotonin reuptake inhibitor (SSRI), has been associated with rare cases of acute pancreatitis. We report a case of sertraline-induced, lipase-sparing acute interstitial edematous pancreatitis in a young professional, initially misdiagnosed as acute cholecystitis. On rechallenge, the patient developed recurrent symptoms with elevated inflammatory markers but normal ultrasound findings. Contrast-enhanced computed tomography confirmed acute interstitial edematous pancreatitis with associated venous thrombosis. Withdrawal of sertraline and substitution with an alternative antidepressant led to complete resolution. This case highlights the diagnostic challenge of lipase-sparing pancreatitis and underscores the importance of considering drug-induced etiologies.
Authors
- Singh SJ
- Midha PK
- Zaparackaite I
- Singh H
- Patel RV
- Swamy KB
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- RK University (IN)
- Mount Sinai Hospital (US)
- Lincoln University College (MY)
- Evelina London Children's Healthcare (GB)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-12-11
- DOI
- https://doi.org/10.5281/zenodo.18058156
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00